{
    "2021-03-15": [
        [
            {
                "time": "",
                "orginal_text": "药明康德现2笔大宗交易合计成交13.70万股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "大宗交易",
                        "成交"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "穆迪：上调药明康德展望至“正面”。并确认其“Baa3”评级",
                "features": {
                    "keywords": [
                        "穆迪",
                        "上调",
                        "药明康德",
                        "正面",
                        "Baa3"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "医药行业周报：胰岛素、精麻药品专项带量采购启动在即",
                "features": {
                    "keywords": [
                        "医药行业",
                        "胰岛素",
                        "精麻药品",
                        "带量采购"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "各种“茅”集体重挫！外资仍在扫货，资金流向低估值赛道？",
                "features": {
                    "keywords": [
                        "茅",
                        "重挫",
                        "外资",
                        "扫货",
                        "低估值"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "药明康德今日大宗交易成交13.70万股，成交价129.21元溢价0.0%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "大宗交易",
                        "成交",
                        "溢价"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "因可转换债券获转换药明康德(02359)发行8.84万股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "可转换债券",
                        "发行"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "医药生物行业周报：年报密集披露 关注业绩超预期个股",
                "features": {
                    "keywords": [
                        "医药生物",
                        "年报",
                        "业绩",
                        "超预期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "收评 | 基金重仓股重挫创业板跌4% 如何应对",
                "features": {
                    "keywords": [
                        "基金",
                        "重仓股",
                        "重挫",
                        "创业板",
                        "跌"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "东吴证券-医药生物行业：医药核心资产，其估值已进入底部区域【行业研究】",
                "features": {
                    "keywords": [
                        "东吴证券",
                        "医药生物",
                        "核心资产",
                        "估值",
                        "底部"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "机构抱团股持续走弱，Wind茅指数跌超3%",
                "features": {
                    "keywords": [
                        "机构",
                        "抱团股",
                        "走弱",
                        "Wind茅指数",
                        "跌"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}